Can albuterol make you shaky
Pro Research Analysisby 
Searched over 200M research papers
Can Albuterol Make You Shaky?
Introduction to Albuterol and Its Uses
Albuterol is a commonly prescribed medication used to treat bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles in the airways and increasing airflow to the lungs. However, like many medications, albuterol can have side effects, one of which is causing shakiness or tremors.
Evidence of Shakiness from Albuterol Use
Pediatric Cases and Nebulized Albuterol
In pediatric cases, the use of nebulized albuterol has been associated with significant side effects, including shakiness. For instance, an 8-year-old male with asthma experienced uncontrollable shaking, elevated heart rate, and diaphoresis after receiving nebulized albuterol treatments every four hours over three days . This case highlights that even in a controlled home environment, albuterol can induce tremors and other systemic effects.
Oral Albuterol in Non-Asthmatic Children
A study involving non-asthmatic children with acute cough also reported increased instances of shaking or trembling in those treated with oral albuterol compared to a placebo group. Specifically, 5 out of 30 children treated with albuterol experienced these side effects, whereas none in the placebo group did . This suggests that even in children without underlying respiratory conditions, albuterol can cause noticeable tremors.
Adult Cases and Oral Albuterol
In adults, the side effects of albuterol are similarly evident. A randomized controlled trial involving 104 adults with acute cough found that those treated with oral albuterol reported significantly more instances of shakiness and nervousness compared to those given a placebo . This study reinforces the observation that albuterol can induce tremors across different age groups and conditions.
Conclusion
The evidence clearly indicates that albuterol, whether administered orally or via nebulization, can cause shakiness or tremors in both children and adults. These side effects are significant enough to be noted in clinical trials and case reports. Therefore, patients and healthcare providers should be aware of these potential side effects when considering albuterol as a treatment option.
Sources and full results
Most relevant research papers on this topic
A randomized controlled trial of oral albuterol in acute cough.
Oral albuterol is ineffective and may cause increased shakiness and nervousness in unselected patients with acute, nonspecific cough.
Regular use of inhaled albuterol and the allergen-induced late asthmatic response.
Regular use of inhaled albuterol (200 micrograms four times daily) increases late asthmatic response and allergen-induced airway responsiveness, potentially causing more airway inflammation than allergen exposure alone.
Improved muscle function in a phase I/II clinical trial of albuterol in Pompe disease.
Extended-release albuterol may improve muscle function in carefully selected patients with late-onset Pompe disease, based on their ability to take it on enzyme replacement therapy.
Acute hypokalemic periodic paralysis possibly precipitated by albuterol.
Inhaled albuterol may cause an exacerbation of hyokalemic periodic paralysis in patients with a history of the condition.
DOI